# Iodine and Thyroid Dysfunction in Ageing: Nutritional, Pharmacologic, and Microbial Modifiers in Older Adults

**Authors:** Corina-Aurelia Zugravu, Marta Petre, Ciprian Constantin

PMC · DOI: 10.3390/geriatrics11010012 · Geriatrics · 2026-01-26

## TL;DR

This review explores how aging affects iodine and thyroid function, highlighting the roles of diet, medications, and gut health in older adults.

## Contribution

The paper integrates evidence on how aging modifies iodine-thyroid interactions, emphasizing nutritional and microbial factors.

## Key findings

- Aging reduces renal iodine clearance and thyroidal reserve, increasing vulnerability to iodine imbalance.
- Polypharmacy and gut dysbiosis further destabilize thyroid function in older adults.
- Age-adjusted thyroid monitoring can improve metabolic resilience and reduce overtreatment.

## Abstract

Background: Ageing profoundly alters endocrine regulation and nutrient metabolism, predisposing older adults to thyroid dysfunction. Iodine, an essential micronutrient, lies at the center of this vulnerability due to its narrow physiological range and multiple interactions with nutrition, medications, renal function, and, presumably, gut microbiota. Objective: This narrative review integrates evidence on how ageing modifies iodine–thyroid homeostasis, emphasizing the roles of dietary intake, pharmacologic exposures, microbiota composition, and age-related metabolic alterations that influence iodine handling and thyroid hormone economy. Main Findings: Physiological ageing reduces renal iodine clearance, thyroidal reserve, and peripheral hormone conversion, while chronic inflammation and multimorbidity increase susceptibility to both iodine deficiency and excess. Polypharmacy, including amiodarone, lithium, and proton pump inhibitors, further destabilizes thyroid function. Age-related dysbiosis may impair micronutrient absorption and immune tolerance, linking gut ecology to thyroid autoimmunity. The gut microbiota may influence thyroid function through immune and metabolic pathways, although current evidence in older adults remains limited. Together, these factors shift the balance between iodine intake and utilization, heightening the risk of subclinical or overt hypothyroidism in older adults. Conclusions: Overall, variations in iodine intake emerge as one of the main determinants of thyroid dysfunction in ageing with nutritional, pharmacologic, and other modifiers primarily influencing iodine-related thyroid vulnerability. The adoption of age-adjusted thyroid reference ranges and preventive monitoring can reduce overtreatment and improve metabolic resilience in later life.

## Linked entities

- **Chemicals:** iodine (PubChem CID 807), amiodarone (PubChem CID 2157), lithium (PubChem CID 28486)
- **Diseases:** hypothyroidism (MONDO:0005420)

## Full-text entities

- **Genes:** TXK (TXK tyrosine kinase) [NCBI Gene 7294] {aka BTKL, PSCTK5, PTK4, RLK, TKL}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, TRH (thyrotropin releasing hormone) [NCBI Gene 7200] {aka Pro-TRH, TRF}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SLC5A5 (solute carrier family 5 member 5) [NCBI Gene 6528] {aka NIS, TDH1}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, DIO1 (iodothyronine deiodinase 1) [NCBI Gene 1733] {aka 5DI, THMA2, TXDI1}, CCK (cholecystokinin) [NCBI Gene 885], GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}
- **Diseases:** metabolic derangements (MESH:D008659), nodular thyroids (MESH:D013966), enteropathy (MESH:C538273), frailty (MESH:D000073496), Iron deficiency (MESH:D000090463), Graves' disease (MESH:D006111), Hashimoto's thyroiditis (MESH:D050031), borderline (MESH:D012569), autoimmune (MESH:D001327), hyperthyroidism (MESH:D006980), vitamin B12 deficiency (MESH:D014806), insufficiencies (MESH:D000309), Dysbiosis (MESH:D064806), renal function decline (MESH:D060825), psychiatric (MESH:D001523), atrophy (MESH:D001284), CKD (MESH:D051436), Zinc deficiency (MESH:C564286), metabolic syndrome (MESH:D024821), fibrosis (MESH:D005355), sarcopenia (MESH:D055948), atrophic gastritis (MESH:D005757), Chronic inflammation (MESH:D007249), injury to (MESH:D014947), Hypochlorhydria (MESH:D000126), dyslipidemia (MESH:D050171), goiter (MESH:D006042), neuromuscular dysfunction (MESH:D009468), immune dysregulation (OMIM:614878), cognitive decline (MESH:D003072), depression (MESH:D003866), kidney disease (MESH:D007674), AITD (MESH:D013967), Thyroid Dysfunction (MESH:D013959), constipation (MESH:D003248), thyrotoxicosis (MESH:C566386), thyroid hypertrophy (MESH:D006984), impaired gastrointestinal absorption (MESH:D005767), Chronic iodine deficiency (MESH:D003409), cardiovascular complications (MESH:D002318), nodular goiter (MESH:D006044), insulin resistance (MESH:D007333), osteoporosis (MESH:D010024), bone loss (MESH:D001847), endotoxemia (MESH:D019446), pancreatic insufficiency (MESH:D010188), nodular disease (MESH:D008224), lactose (MESH:D007787), atherosclerosis (MESH:D050197), Hypothyroidism (MESH:D007037), Selenium deficiency (MESH:D007153), micronutrient malabsorption (MESH:D008286), hypertension (MESH:D006973)
- **Chemicals:** sorafenib (MESH:D000077157), iodide (MESH:D007454), methimazole (MESH:D008713), sunitinib (MESH:D000077210), Iron (MESH:D007501), Lithium (MESH:D008094), DIT (MESH:D004105), Zinc (MESH:D015032), salt (MESH:D012492), T3 (MESH:D014284), Calcium (MESH:D002118), SCFA (MESH:D005232), povidone-iodine (MESH:D011206), Prebiotics (MESH:D056692), Amiodarone (MESH:D000638), Iodine (MESH:D007455), lipid (MESH:D008055), LPS (MESH:D008070), butyrate (MESH:D002087), colestipol (MESH:D003084), rifampicin (MESH:D012293), Selenium (MESH:D012643), MIT (MESH:D007470), Bile acid (MESH:D001647), iodized salt (MESH:C034024), FT3 (-), Levothyroxine (MESH:D013974), iodophor (MESH:D007466), cholestyramine (MESH:D002792), sodium (MESH:D012964)
- **Species:** Lacticaseibacillus rhamnosus (species) [taxon 47715], Bifidobacterium longum (species) [taxon 216816], Limosilactobacillus reuteri (species) [taxon 1598], Bacteroides (genus) [taxon 816], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922011/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922011/full.md

## References

119 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922011/full.md

---
Source: https://tomesphere.com/paper/PMC12922011